Hinge Bio
Clinical trials sponsored by Hinge Bio, explained in plain language.
-
New lupus drug candidate enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug called HB2198 in 30 adults with moderate-to-severe lupus, including kidney inflammation. The drug is designed to target and deplete certain immune cells (B cells) that drive the disease. The main goals are to check safety, find the best dos…
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Disease control
Last updated May 26, 2026 10:51 UTC
-
New antibody drug tested in healthy volunteers for first time
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called HB2198 in 32 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose of the drug or a placebo and are monitored for about two months. The study focuses on safety and drug levels in the bl…
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Knowledge-focused
Last updated May 26, 2026 10:48 UTC